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htcense.Abstract Objective: To compare the prevalence and the anatomic distribution of acute PE in
oncology patients with those of non oncology patients using multidetector CT (MDCT) pulmonary
angiography.
Material and methods: We prospectively reviewed 80 consecutive patients having pathologically
proven neoplasms and clinically suspected to have acute PE. Similarly, the other group included
80 consecutive age-matched patients with the clinical suspicion of acute PE, nonetheless, with irrel-
evant oncologic history. All patients underwent MDCT pulmonary angiography. The PE involve-
ment according to pulmonary arterial level was classiﬁed. Lobar location was also recorded using
standard nomenclature.
Results: Twenty six patients (33%) of the 80 oncology patients compared to 19 patients (24%) of
the 80 non oncology group had acute PE at pulmonary MDCT angiographic examinations. Among
the oncology patients, acute PE was located in the main pulmonary artery in 7 (13%), the lobar
pulmonary artery in 22 (40%), the segmental pulmonary artery in 17 (31%) and the subsegmental
pulmonary artery in 9 (16%) patients. Whereas in the non oncology group, the level of involvement
of PE was the main pulmonary artery in 4 (10%) patients, the lobar pulmonary artery in 17 (40%),
the segmental pulmonary artery in 15 (36%) and the subsegmental pulmonary artery in 6 (14%).
Alternatively, there was a lower lobar predominance in both groups.
Conclusion: The prevalence of acute PE is more common among oncology patients than previously
reported and has a slight predilection to a central distribution.
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Medicine. Open access under CC BY-NC-ND license.1005285089.
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Pulmonary embolism (PE) is a potentially life-threatening con-
dition and is responsible for signiﬁcant morbidity and mortal-
ity in adults (1,2). Cancer and its treatment are recognized risk
factors for venous thromboembolism (VTE). It has beengyptian Society of Radiology and Nuclear Medicine.
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patients with cancer compared to those without (3). Moreover,
the venous thromboembolic complication, pulmonary embo-
lism (PE), is an important cause of death in cancer patients
(4–6). Depending on the clinical presentation, the case fatality
rate for acute pulmonary embolism ranges from about 60% to
less than 1% (7). Trousseau in 1865 hypothesized that the
procoagulant activity generated by tumor cells, macrophages,
platelets and vascular endothelial cells contributed to a
thrombophilic state in cancer patients (8). The use of newer
and more aggressive chemotherapeutic agents has also been
associated with an increased risk for thrombosis (7). PE is a
difﬁcult diagnosis to make on the basis of clinical and labora-
tory data alone. Thus, imaging studies play a critical role in
establishing this diagnosis (9). During the past decade, CT pul-
monary angiography has revolutionized the imaging of PE in
adults and is now considered the reference standard for diag-
nosis (10,11).
With MDCT volumetric isotropic data on the entire thorax
are acquired with thin collimation and few artifacts; therefore,
images can be viewed in any plane (12–17). Multidetector row
helical computed tomography (CT) is particularly helpful in
the diagnosis of acute pulmonary embolism (PE) owing to its
capacity to directly show emboli as intravascular ﬁlling defects
(18). Moreover, with the advent of MDCT scanners, even the
subsegmental pulmonary arteries can now be evaluated (19).
MDCT pulmonary angiography has also been shown to have
high speciﬁcity, sensitivity and negative predictive value for the
diagnosis of acute PTE (20,21).
Thus, CT pulmonary angiography has become a commonly
used non invasive modality for the diagnosis of PE (22).
Likewise, MDCT pulmonary angiography is becoming the
standard of care at many institutions for the evaluation of pa-
tients with suspected pulmonary embolism (23).
The purpose of this study is to compare the prevalence and
the anatomic distribution of acute PE in a cohort of consecu-
tively selected oncology patients who are imaged with MDCT
pulmonary angiography for the clinical suspicion of acute PE
with those of consecutive age-matched patients clinically sus-
pected to have acute PE, nonetheless, with irrelevant oncologic
history.
2. Material and methods
2.1. Patients
Between April 2011 and November 2012, 80 consecutive
oncology patients who had a pathologically conﬁrmed diagno-
sis of cancer and were suspected of having acute PE, based on
relevant clinical history, symptoms and vital signs were eligible
for the study. They were included in the order they showed up
and gave their informed written consents. They underwent
MDCT pulmonary angiography. Demographic data including
age and type of underlying neoplasm and disease stage were re-
corded. The presence of known metastasis, history of surgery,
chemotherapy, radiation therapy or hormonal treatment was
also recorded for each patient.
Likewise, 80 consecutive age-matched patients with the
clinical suspicion of acute PE, however, with irrelevant onco-
logic history were enrolled in this study. The protocol of our
study was approved by the Committee of Ethics.We excluded patients with a history of previous PE, those
with equivocal MDCT pulmonary angiographic examination
and those with suboptimal quality of MDCT pulmonary
angiographic images due to insufﬁcient contrast opaciﬁcation
within the pulmonary arteries or the presence of artifacts lim-
iting the evaluation of pulmonary arteries due to beam harden-
ing or motion. In addition, patients with clinical symptoms of
acute PE who had contraindications for a MDCT pulmonary
angiography (renal failure and/or allergy to iodine contrast)
were excluded and instead, they underwent ventilation/perfu-
sion pulmonary scintigraphy.
3. Methods
3.1. CT Protocol and image evaluation
All patients underwent MDCT pulmonary angiography as
follows:
An 18- or 20-gauge catheter was introduced into an upper
extremity peripheral vein under complete aseptic condition.
A volume of 120 mL bolus of non-ionic iodinated contrast
material (iopromide 370 mg I/mL, Ultravist 370, Bayer
HealthCare) was injected via a power injector (Stellant, Med-
rad, Indianola, PA) at a rate of 3–4 ml/sec followed by 20 mL
of normal saline chasing. The start of image acquisition was
determined by using an automatic detection of contrast (auto-
matic triggering) by a bolus-tracking technique (CARE-Bolus,
Siemens Medical Solutions, Erlangen, Germany) with contrast
monitoring cursor placed in the main pulmonary artery. Con-
trast scanning was initiated when attenuation in the main pul-
monary artery reaches 70 HU. Single breath hold scans were
obtained.
Axial CT was performed with 16-section multidetector CT
scanners (Somatom Sensation 16, Siemens Medical Solutions,
Erlangen, Germany). Images were acquired from the lung
bases to the apices using the following parameters: a peak volt-
age of 120 kVp, a tube current of 130 mAs, rotation time of
0.5 s, a detector collimation of 1.5 mm, a table movement of
15 mm per rotation with 2 mm slice thickness.
All images were sent to an ofﬂine workstation (Siemens
Syngo). Image reconstruction from 2 cm below the diaphragm
to the aortic arch was performed using 1.25 mm section thick-
ness with 0.8 mm spacing. Images were reconstructed using
multiplanar reformation (e.g., coronal and sagittal reforma-
tion) as this differentiates between true pulmonary embolism
and a variety of patient-related, technical, anatomic and path-
ologic factors that can mimic pulmonary embolism (23).
Images were displayed using a standard lung window (window
width/level [HU], 1500/600) and a standard mediastinal win-
dow (400/40). However, during evaluation, reviewers could
also manually alter the window width or level settings and
zoom into areas of interest.
MDCT pulmonary angiograms were interpreted separately
by two independent experienced radiologists (having more
than 10 years experience interpreting chest CT images) using
the subsequently reported criteria for the diagnosis of pulmon-
ary embolism. The two independent experienced radiologists
were blinded to the type of the underlying neoplasm in the pa-
tients of the oncology group.
An angiogram was considered positive for acute PE if there
was an intraluminal ﬁlling defect on more than one contiguous
Table 1 Shows the type of cancer and the number of patients
with their percentages.
Type of cancer Number of patients Percentage
Bronchogenic carcinoma 9 11
Lymphoma 13 16
Breast cancer 7 9
Colorectal carcinoma 15 19
Hepatocellular carcinoma 17 21
Ovarian adenocarcinoma 11 14
Gastric carcinoma 8 10
Fig. 1 Pulmonary arterial levels involved in the patients of acute
PE in the oncology group.
Fig. 2 Pulmonary arterial levels involved in the patients of acute
PE in the non oncology group.
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with expansion of the vessel and/or an abrupt termination of
the opaciﬁed vessel peripherally. On the other hand, if neither
of these ﬁndings was present, an angiogram was considered
negative for acute PE. Equivocal angiograms were considered
if there was a questionable ﬁlling defect on one or two images
(24). However, the equivocal angiograms are not included in
our study. We also evaluated the images using lung window
settings for the presence of the ancillary ﬁnding of pulmonary
infarct which is demonstrated as a peripheral wedge-shaped
area of hyperattenuation along with linear bands (23). Diag-
nostic criteria for acute PE positive angiograms also included
the visualization of a ‘polo mint’ or ‘railway track’ appearance
where embolus is surrounded by contrast enhanced blood
(25,26). A ‘‘polo mint’’ sign is seen when a partial ﬁlling defect
surrounded by contrast material on images acquired perpen-
dicular to the long axis of a vessel, while, the ‘‘railway track’’
sign is seen when a partial ﬁlling defect surrounded by contrast
material on longitudinal images of the vessel (23).
For each lung, the main, lobar, segmental and subsegmen-
tal arteries were examined for pulmonary embolism. Embolus
location was recorded according to the size of the affected pul-
monary arterial vessels being classiﬁed as (main pulmonary ar-
tery, right pulmonary artery, left pulmonary artery), lobar
(interlobar and lobar) or small vessel (segmental and subseg-
mental pulmonary artery) (24). Categorically, an embolus
was assigned to the ‘‘central’’ group if there was radiologic evi-
dence of a PE in the main stem, the right or the left pulmonaryTable 2 The distribution of pulmonary artery levels for the pulmon
groups; oncology and non oncology.
Type of patients included MPA L
Oncology group 7/55 (13%) 22
Non Oncology group 4/42 (10%) 17
MPA=main pulmonary artery, LPA = lobar pulmonary artery, SPA
artery.
Table 3 The lobar involvement of the pulmonary emboli detected o
non oncology.
Type of patients included RUL RML R
Oncology group 8/56 (14%) 5/56 (9%) 2
Non Oncology group 7/44 (16%) 5/44 (11%) 1
RUL= right upper lobe, RML= right middle lobe, RLL = right lowerartery, the interlobar or lobar arteries alone with or without
concomitant small vessel involvement. All the other patients
with ﬁlling defects in one or more small vessels were assigned
to the ‘‘peripheral’’ group.
Also, the distribution of the embolus between different lung
lobes on both sides was recorded. A lobar location was alsoary emboli detected on MDCT pulmonary angiography in both
PA SPA SSPA
/55 (40%) 17/55 (31%) 9/55 (16%)
/42 (40%) 15/42 (36%) 6/42 (14%)
= segmental pulmonary artery, SSPA= subsegmental pulmonary
n MDCT pulmonary angiography in both groups; oncology and
LL LUL Lingula LLL
0/56 (36%) 4/56 (7%) 4/56 (7%) 15/56 (27%)
8/44 (41%) 2/44 (5%) 3/44 (7%) 9/44 (20%)
lobe, LUL= left upper lobe, LLL= left lower lobe.
Fig. 3 A patient of pathologically proven colorectal carcinoma, consecutive axial (A and B) and coronal (C and D) MDCT pulmonary
angiographic images show ﬁlling defects of pulmonary embolism (arrowed) in segmental and subsegmental arteries of the right middle
lung lobe. Sagittal reformatted MDCT pulmonary angiographic image (E) displays detailed visualization of the course of obliquely
oriented segmental and subsegmental branches containing the ﬁlling defects of the pulmonary emboli.
466 R. Refaat, M.A. El-Shinnawydetermined using standard nomenclature of Boyden (27) and
Jackson and Huber (28): right upper lobe (RUL), right middle
lobe (RML), right lower lobe (RLL), left upper lobe (LUL),
lingula and left lower lobe (LLL). Location and level were
determined on a per-embolus basis rather than a per-patient
basis because several patients had more than one embolism.
Furthermore, we measured the maximum minor axis of the
right ventricle and the maximum minor axis of the left ventricle
(LV) to assess for the right ventricular strain. The right ventri-
cle (RV) was considered dilated if the RV cavity was wider
than the LV cavity along the short axis (23). Similarly, the
images were evaluated using the mediastinal window settings
for evaluation of associated mediastinal adenopathies.4. Results
The mean age of the oncology group was 61 years versus
63 years in the non oncology group. In addition, the oncology
group consisted of 54% male patients and 46% female pa-
tients, whereas, the non oncology group consisted of 51% male
patients and 49% female patients.
4.1. Types of cancer
In the oncology group, the patients included had diverse types
of cancer; lymphoma in 13 patients (16%), breast cancer in 7
Fig. 4 A patient of pathologically proven lymphoma, axial MDCT pulmonary angiography images (A and B) showing two ﬁlling defects
of pulmonary emboli noted within the right main pulmonary artery.
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(19%), bronchogenic carcinoma in 9 patients (11%), hepato-
cellular carcinoma in 17 patients (21%), ovarian adenocarci-
noma in 11 patients (14%) and gastric carcinoma in 8
patients (10%) (Table 1). The majority of patients had
advanced disease stage; 43 patients (53.8%) had stage IV
and 27 patients (33.8%) had stage III, whereas, only 3 patients
(3.7%) had stage I and 7 patients (8.7%) had stage II. All
patients were undergoing active treatment; 59 patients (74%)
with chemotherapy, 21 patients (26%) with radiotherapy;
none, however, were on hormonal therapy or had recently
undergone surgery.
On the other hand, the oncology patients having positive
angiograms for acute PE were diagnosed to have lymphoma
in 7 patients (26.9%), bronchogenic carcinoma in 4 patients
(15.4%), hepatocellular carcinoma in 4 patients (15.4%), ovar-
ian adenocarcinoma in 6 patients (23.1%) and colorectal can-
cer in 5 patients (19.2%). No positive cases for acute PE were
identiﬁed in any of the included patients with gastric carci-
noma or breast cancer. All of them had advanced disease stage
of stage IV. Regarding the treatment given, 22 of them (85%)
(the patients who were diagnosed to have colorectal carci-
noma, ovarian adenocarcinoma and lymphoma) had their
PE while receiving their chemotherapeutic treatment while
the other 4 cases (15%) of hepatocellular carcinoma were trea-
ted with palliative chemoembolization.
We did not ﬁnd a signiﬁcant association between the pres-
ence of acute PE and a speciﬁc type of neoplasm. However,
this is explained by the few number of positive cases of acute
PE for each type of cancer which limited our ability to make
a deﬁnitive statement about such potential association.Fig. 5 MDCT pulmonary angiography images in axial (A),
coronal (B) and sagittal (C) planes at the level of the basal
subsegmental pulmonary artery show multifocal low-attenuation
emboli (arrowed) in segmental and subsegmental arteries of the
right lower lobe.4.2. CT pulmonary angiography results
In all included 160 patients, the two independent experienced
radiologists veriﬁed the technical adequacy of the performed
MDCT angiographic images. All MDCT pulmonary angio-
graphic studies were technically successful in visualizing arter-
ies to the level of subsegmental pulmonary arteries. Of the
160 patients included 45 (28%) had a CT angiogram that
was positive and 115 patients (72%) had a CT angiogram
that was negative for acute PE. Of the 45 patients who had
acute PE detected at MDCT pulmonary angiography, 26 pa-
tients out of 45 patients (58%) belonged to the oncology pa-
tients and the other 19 patients out of the 45 patients (42%)
Fig. 6 Axial oblique MPR images of MDCT pulmonary angiography (A and B) assuming the sagittal orientation and showing
intraluminal ﬁlling defects that occlude the right and the left interlobar arteries with further extension into posterior basal segmental and
subsegmental arteries of both lower lung lobes.
Fig. 7 The lobar involvement in the patients of acute PE in the
oncology group.
Fig. 8 The lobar involvement in the patients of acute PE in the
non oncology group.
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patients, the acute PE positive MDCT pulmonary angio-
grams were 26 patients out of the 80 patients (33%) com-
pared to 19 patients out of the 80 patients (24%) in the
non oncology group of patients.4.3. Distribution of PE
The anatomic location of PE is listed below in Tables 2 and 3,
the distribution of pulmonary artery levels for the pulmonary
emboli detected on MDCT pulmonary angiography (Table 2)
was subsegmental in 9 patients (16%) of the oncology group
versus 6 patients (14%) in the non oncology group, segmental
in 17 patients (31%) in the oncology group versus 15 patients
(36%) in the non oncology group, lobar in 22 patients (40%)
in the oncology group versus 17 patients (40%) in the non
oncology group and main pulmonary artery in 7 patients
(13%) in the oncology group versus 4 patients (10%) in the
non oncology group (Figs. 1 and 2). There was no case in
which subsegmental PE was an isolated ﬁnding without evi-
dence of additional PE at a more proximal level.
Consequently, assigning the detected emboli to central
group or peripheral group, the oncology group showed 26 em-
boli in the peripheral group (Fig. 3) and 29 emboli in the cen-
tral group (Fig. 4). On the other hand, the non oncology group
showed equal number of emboli in the peripheral (Fig. 5) and
central groups (Fig. 6), being 21 in each.
Regarding the lobar involvement of pulmonary emboli (Ta-
ble 3), in the oncology group, the detected pulmonary emboli
involved RUL in 8 patients (14%), RML in 5 patients (9%),
RLL in 20 patients (36%), LUL in 4 patients (7%), lingula
in 4 patients (7%) and LLL in 15 patients (27%) (Fig. 7).
Acute PE was bilateral in 13 patients (50%), unilateral in the
right lung in 9 patients (35%) and unilateral in the left lung
in 4 patients (15%). A single lobar location was found in 12
patients (46%), two lobar locations in 6 patients (23%) and
multiple lobar locations (>2 lobes) in 8 patients (31%).
As shown in Table 3, regarding the lobar affection of the
detected pulmonary emboli in the non oncology group, they
involved RUL in 7 patients (16%), RML in 5 patients
(11%), RLL in 18 patients (41%), LUL in 2 patients (5%), lin-
gula in 3 patients (7%) and LLL in 9 patients (20%) (Fig. 8).
PE was bilateral in 11 patients (58%), unilateral in the right
lung in 7 patients (37%) and unilateral in the left lung in 1 pa-
tient (5%). A single lobar location was found in 5 patients
Fig. 9 MDCT axial (A, B and C) pulmonary angiographic images showing ﬁlling defects of a pulmonary embolus affecting the
segmental arteries of the laterobasal and posterobasal segments of the right lower lobe. These partial ﬁlling defects are surrounded by
contrast material producing the so-called ‘‘polo mint sign’’ (arrowed). The arteries are enlarged compared with adjacent patent vessels.
Postcontrast CT abdomen (D) shows a hyperenhancing oval shaped hepatic focal lesion which is consistent with the primary HCC in the
posterior segment of the right hepatic lobe (segment VI). Internal non enhancing hypodense areas are seen within this focal lesion.
Fig. 10 This is the same patient seen in Fig. 4 who was
pathologically proven to have lymphoma. Oblique MPR view of
MDCT pulmonary angiography showing intuitive visualization of
the extent of embolus having the so-called ‘‘railway track’’ sign
(arrowed).
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ple lobar locations (>2 lobes) in 5 patients (26.3%).
Note is made that not only the PE involving one lobe may
also involve more than one pulmonary artery location but also
the PE involving different lobes may be detected in same pul-
monary artery location.We also noted the diagnostic criteria for acute PE positive
angiograms of ‘‘polo mint’’ sign (Figs. 9 and 12A) and ‘‘rail-
way track’’ sign (Figs. 10 and 12C) in our study.
The ancillary ﬁnding of pulmonary infarct (Figs. 11 and
12A and B) was detected in 3 patients belonging to the non
oncology group of patients.
Additionally, the right ventricle was dilated in 8 patients
positive for acute PE belonging to the non oncology group
(Figs. 12A and 13). There were enlarged mediastinal lymph
nodes in the case of lymphoma implicating the pretracheal ret-
rocaval region, prevascular aortic space, retrosternal space and
subcarinal region (Fig. 14).
5. Discussion
In this study, we found a 33% prevalence of acute PE among a
consecutive group of oncology patients referred for pulmonary
CTA with clinical suspicion acute PE opposed to that of 24%
among the non oncology group of patients. These results are
compared to the 23.3% prevalence of PE reported in the recent
adult PIOPED II (Prospective Investigation of Pulmonary
Embolism Diagnosis) trial (29). In addition, Hui and other col-
leagues (30) found that the prevalence of symptomatic PE on
dedicated CT pulmonary angiography was 11.8%. On the
other hand, Gladish et al (31) found that incidental pulmonary
emboli were seen in 16 oncology patients (4%) but were ini-
tially reported in only four of them being explained by the
small size of involved arteries which contributes to the failed
detection at initial CT image interpretation.
Fig. 11 MDCT pulmonary angiographic images; axial (A and B) and sagittal in mediastinal window settings (C and D) and in lung
window settings (E and F) at the level of the of the basal segmental and subsegmental arteries of both lower lung lobes showing occlusion
of the posterior basal segmental and subsegmental arteries of both lower lung lobes (white arrow in A–D) with a pleural-based and wedge-
shaped area of hyperattenuation in the corresponding lung (black arrow in C–F), an ancillary ﬁnding of pulmonary infarct.
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presence of acute PE in the oncology patients and a speciﬁc
type of cancer. This concurs with Lee et al (32) who studied
the MDCT of pulmonary emboli in pediatric oncology pa-
tients. However, Thodiyil et al (33) concluded from their study
that the risk of VTE varies by cancer type and is especially
high among patients with malignant brain tumors and adeno-
carcinoma of the ovary, pancreas, colon, stomach, lung and
prostate. Other studies showed that a variety of tumors,including pancreatic, ovarian and brain tumors, are associated
with an increased risk of pulmonary emboli and deep venous
thrombosis (6,34). Alternatively, the study done by Gladish
et al (31) revealed that patients with gynecologic malignancies
and melanoma had a trend toward a higher prevalence of pul-
monary emboli compared with the overall group.
On the other hand, Karippot and other colleagues (35)
found that genitourinary cancer was most commonly associ-
ated with VTE followed by gastrointestinal, then lung cancer,
Fig. 12 Axial MDCT pulmonary angiographic images in mediastinal window settings (A) and in lung window settings (B) at the level of
the basal subsegemental pulmonary arteries revealing multifocal low-attenuation emboli producing the so-called ‘‘polo mint’’ sign (dashed
arrow in A) in segmental and subsegmental arteries of the right lower lobe with a pleural-based and wedge-shaped area of
hyperattenuation in the corresponding lung (white arrow in A and B). The latter represents the ancillary ﬁnding of pulmonary infarct. A
note is also made on right ventricular strain caused by the acute pulmonary embolism denoted by wider short axis of the right ventricle
(dashed line in A) in comparison to that of the left ventricle (solid line in A). Oblique MPR view of MDCT pulmonary angiography (C)
showing the partial ﬁlling defects (arrowed) of the pulmonary emboli surrounded by contrast material on the longitudinal image of the
vessel representing the so-called ‘‘railway track’’ sign.
Does the anatomic distribution of acute pulmonary emboli at MDCT pulmonary angiography 471breast cancer, hematologic malignancies, melanoma and CNS
tumors. Moreover, previous works in cancer patients with
symptomatic VTE showed that the risk of VTE is lower in sites
such as skin, breast and thyroid (36,37).
The advanced disease stage identiﬁed in all our patients was
associated with higher risk of PE. This goes in agreement with
Blom et al (38) who conﬁrmed that though the risk of VTE
varies with the stage of the disease, it is much higher with ad-
vanced stage than with early disease stage. Likewise, Chew and
other colleagues (39) detected that the incidence of venous
thromboembolism was highest among patients initially diag-
nosed with metastatic disease stage. In that study, they inferred
that compared to patients with localized disease, the relative
risk of developing symptomatic thromboembolism was more
than 20-fold higher for metastatic melanoma, 9-fold higher
for metastatic bladder cancer and 5- to 6-fold higher among
patients with metastatic breast or uterine cancer. They also
suggested that the biological aggressiveness of the cancer
may be the principal risk factor associated with developmentof thromboembolism. As a result, they stated that the inci-
dence of thromboembolism for some types of cancer was suf-
ﬁciently high to warrant prospective clinical trials of primary
thromboprophylaxis.
All patients in our study were undergoing active treatment;
59 patients (74%) with chemotherapy and 21 patients (26%)
with radiotherapy. Karippot and other colleagues (35) estab-
lished that pulmonary embolism is a common and potentially
lethal disease in active cancer patients. In addition, Haddad
and Greeno (40) deduced that the risk is also higher among
cancer patients on active treatment with chemotherapy or
radiotherapy. Whereas, Gladish et al (31) found that about
one third of patients were currently undergoing chemotherapy
or had completed their most recent course of chemotherapy
within 1 month and few patients had recently undergone sur-
gery or radiation therapy. Chew and other colleagues (39) also
declared that major surgery, chemotherapy or radiation treat-
ment contribute to the high incidence of thromboembolism in
the months immediately following the diagnosis of cancer.
Fig. 13 Axial images of MDCT pulmonary angiography (A and B) at the level of the basal subsegemental pulmonary arteries showing
multifocal low-attenuation emboli involving the subsegmental arteries of both lower lung lobes (arrowed). Also the short axis of the right
ventricle (dashed line) is wider than that of the left ventricle (solid line) representing right ventricular strain caused by the acute pulmonary
embolism.
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PE in cancer patients, similar to symptomatic PE, with ad-
vanced disease stage and while undergoing active anti-cancer
therapy. In that study, a signiﬁcant percentage of patients
had recurrent emboli pulmonary hypertension and sudden
death.
The patients of the oncology group in our study comprised
26 peripheral and 29 central emboli. Our results are in agree-
ment with Hasenberg et al (42) who reported higher incidence
rate of central PEs in patients with malignant disease than pa-
tients without malignancies being about twofold in the earlier.
Karippot and other colleagues (35) accomplished that active
cancer patients appear to be at a higher risk for central PEreporting 63.4% incidence in the cancer group compared to
31.9% in the non-cancer group which they explained by the
hypothesis of increased procoagulant activity in malignancy,
in turn translating into extensive VTE.
As shown in Figs. 1 and 2, the pulmonary artery levels
being involved in the acute PE in both groups whether oncol-
ogy or non oncology patients were in order of frequency of
affection: LPA, SPA, SSPA and MPA. The affection was lobar
in 22 patients (40%), segmental in 17 patients (31%), subseg-
mental in 9 patients (16%) and main pulmonary artery in 7 pa-
tients (13%) in the oncology group, while, lobar in 17 patients
(40%), segmental in 15 patients (36%), subsegmental in 6 pa-
tients (14%) and main pulmonary artery in 4 patients (10%) in
Fig. 14 Sequential axial (A–D) MDCT pulmonary angiography images displaying multiple enlarged mediastinal lymph nodes at the
retrosternal space (arrows in A and B), pretracheal retrocaval region (solid arrow in C), prevascular aortic space (dashed arrow in C) and
subcarinal region (arrowed in D).
Does the anatomic distribution of acute pulmonary emboli at MDCT pulmonary angiography 473the non oncology group. This has a similar distribution to that
in pediatric patients with clinically suspected PE (9).
Conversely, another study done by Lee et al (32) to de-
tect unsuspected PE in routine thoracic MDCT examina-
tions of pediatric oncology patients revealed that the
pulmonary arterial locations of 17 emboli were nine (53%)
segmental, ﬁve (29%) lobar, two (12%) central and one
(6%) subsegmental.
With respect to the distribution of PE, the lower lobe pre-
dominance was evident in our study in both groups which cor-
responds with what was noted in other studies (2,31,43,44).
Moreover, this is similar to that observed in particular pediat-
ric population whether general pediatric population with PE
(9) or oncology pediatric patients, in particular (32).
The few number of positive cases for acute PE for each type
of cancer limits our ability to make an ultimate statement
about the association between acute PE and speciﬁc type of
cancer. A larger multicenter study would be helpful to more
fully appraise this association.
To conclude, PE in oncology patients is more common than
previously thought. This could be explained by the increased
procoagulant activity in malignancy and the active anti-cancer
therapy given. It tends to have a slight more central predilec-
tion. Additionally, it affects patients with advanced disease
stage and those undergoing active anti-cancer therapy, thus,
it may warrant primary thromboprophylaxis.
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